CORT Corcept Therapeutics Incorporated

11.96
+0.03  (+0%)
Previous Close 11.93
Open 11.85
Price To Book 4.98
Market Cap 1372090441
Shares 114,723,281
Volume 656,344
Short Ratio
Av. Daily Volume 952,525

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved February 17, 2012.
Corlux - Korlym
Cushing's Syndrome
Phase 2 ongoing.
Mifepristone plus enzalutamide
Castration-resistant prostate cancer (CRPC)
Phase 1/2 data released December 10, 2016 - 4/21 partial responses.
Mifepristone in combination with eribulin
Cancer - triple-negative breast cancer
Phase 2 pancreatic data due 2Q 2019.
Relacorilant
Solid tumors - cancer
Phase 3 commencement of enrolment announced November 19, 2018.
Relacorilant
Cushing’s syndrome
Phase 2 trial initiated January 2019.
Relacorilant plus Abraxane
Ovarian cancer
Phase 2 trial to be initiated 2H 2019.
CORT118335
Nonalcoholic steatohepatitis (NASH)

Latest News

  1. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
  2. Corcept Therapeutics to Present Data at the 2019 American Association of Clinical Endocrinologists’ 28th Annual Congress
  3. FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CORT, CAG and VNDA
  4. NIO, CORT & UMC - Bronstein, Gewirtz & Grossman, LLC  Reminds Investors of Class Action
  5. CORT DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated – CORT
  6. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, MBT and MWA
  7. Class Action - Bronstein, Gewirtz & Grossman, LLC NIO, CORT & UMC
  8. CLASS ACTION UPDATE for CORT, AVEO, DPLO and MBT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  9. Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Corcept, Mobile TeleSystems, Healthcare Services, and American Renal and Encourages Investors to Contact the Firm
  10. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, HCSG, INGN and CRBP
  11. IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corcept Therapeutics Incorporated and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  12. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CORT, CNDT and NIO
  13. CLASS ACTION UPDATE for CORT, STMP and SYNH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  14. Class Action Reminder Bronstein, Gewirtz & Grossman, LLC NIO, CORT & UMC
  15. SHAREHOLDER ALERT: CORT STMP NIO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  16. LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm
  17. CLASS ACTION UPDATE for CORT, STMP and BPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
  18. INVESTOR ALERT: Kaskela Law LLC Announces Important Shareholder Class Action Lawsuit Deadlines – CORT, HCSG, ARA and AMRS
  19. FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CORT, STMP and MBT